USD 1.56
(-17.46%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.52 Million | -2.98 Million | -2.8 Million | -297.05 Thousand | -894.47 Thousand | -1.1 Million |
Net Income | -5.48 Million | -4.48 Million | -6.17 Million | -2.93 Million | -2.72 Million | -3.33 Million |
Depreciation & Amortization | 287.72 Thousand | 368.95 Thousand | 318.26 Thousand | 169.71 Thousand | 91.4 Thousand | 37.01 Thousand |
Deferred income taxes | - | - | - | -12.93 Thousand | 678.77 Thousand | - |
Stock-based compensation | 742.69 Thousand | 732.13 Thousand | 897.83 Thousand | 2 Million | 252.7 Thousand | 1.76 Million |
Change in working capital | 223.21 Thousand | -219.31 Thousand | -541.37 Thousand | 110.22 Thousand | 712.96 Thousand | 400.51 Thousand |
Other non-cash items | 1.91 Million | 614.5 Thousand | 2.22 Million | 363.88 Thousand | 91.31 Thousand | 24.3 Thousand |
Investing Cash Flow | -51.76 Thousand | -79.3 Thousand | -81.59 Thousand | 66.99 Thousand | - | -404.16 Thousand |
Investments in PPE | -51.76 Thousand | -79.3 Thousand | -81.59 Thousand | - | - | -4163.00 |
Acquisitions | - | - | - | 66.99 Thousand | - | -400 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -51.76 Thousand | -79.3 Thousand | -81.59 Thousand | 66.99 Thousand | - | -404.16 Thousand |
Financing Cash Flow | 2.08 Million | 160.07 Thousand | 7.63 Million | 371.87 Thousand | 430.25 Thousand | 1.98 Million |
Debt repayment | -2.08 Million | -17.79 Thousand | -1.62 Million | -356.41 Thousand | -175 Thousand | -42.85 Thousand |
Dividends payments | - | - | -196.58 Thousand | - | - | - |
Common Stock Repurchased | - | -119 Thousand | -104.46 Thousand | - | - | - |
Common Stock Issuance | 2.6 Million | 296.87 Thousand | 6.41 Million | 515.1 Thousand | 250 Thousand | 1.5 Million |
Other Financing Activities | -1.00 | 296.87 Thousand | 3.13 Million | 213.17 Thousand | 355.25 Thousand | 526.73 Thousand |
Accounts receivables | -153.96 Thousand | -41.66 Thousand | 42.96 Thousand | -94.75 Thousand | 255.00 | -12.82 Thousand |
Accounts payables | 198.89 Thousand | -104.86 Thousand | -145.25 Thousand | 155.21 Thousand | 720.15 Thousand | 337.98 Thousand |
Inventory | 60.73 Thousand | -97.68 Thousand | -78.8 Thousand | -10.23 Thousand | -720.15 Thousand | 4133.00 |
Other working capital | 117.56 Thousand | 24.89 Thousand | -360.28 Thousand | 59.99 Thousand | 712.7 Thousand | 71.22 Thousand |
Cash at beginning of period | 1.98 Million | 4.89 Million | 151.99 Thousand | 10.18 Thousand | 474.65 Thousand | - |
Cash at end of period | 492.94 Thousand | 1.98 Million | 4.89 Million | 151.99 Thousand | 10.18 Thousand | 474.65 Thousand |
Capital Expenditure | -51.76 Thousand | -79.3 Thousand | -81.59 Thousand | - | - | -4163.00 |
Effect of forex changes on cash | - | - | - | - | -252.00 | 394.00 |
Net cash flow / Change in cash | -1.49 Million | -2.9 Million | 4.73 Million | 141.81 Thousand | -464.47 Thousand | 474.65 Thousand |
Free Cash Flow | -3.57 Million | -3.06 Million | -2.89 Million | -297.05 Thousand | -894.47 Thousand | -1.1 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.7 Million | -1.89 Million | -1.88 Million | -5.48 Million | -1.75 Million | -829.17 Thousand |
Depreciation & Amortization | 69.94 Thousand | 69.1 Thousand | 69.34 Thousand | 287.72 Thousand | 52.18 Thousand | 83.15 Thousand |
Deferred income taxes | - | - | 322.89 Thousand | - | - | - |
Stock-based compensation | 130.38 Thousand | 422.95 Thousand | -499.85 Thousand | 742.69 Thousand | 580.57 Thousand | - |
Change in working capital | -414.49 Thousand | 564.25 Thousand | 424.59 Thousand | 223.21 Thousand | 39.38 Thousand | -260.95 Thousand |
Other non-cash items | 893.22 Thousand | 192.93 Thousand | 541.23 Thousand | 1.91 Million | 23.53 Thousand | 11.83 Thousand |
Investing Cash Flow | -38.89 Thousand | -6195.00 | -49.13 Thousand | -51.76 Thousand | - | - |
Investments in PPE | -38.89 Thousand | -6195.00 | -49.13 Thousand | -51.76 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -6195.00 | -51.76 Thousand | -51.76 Thousand | - | - |
Financing Cash Flow | -5136.00 | 8.69 Million | -5004.00 | 2.08 Million | -4960.00 | 2.05 Million |
Debt repayment | -5136.00 | -294.91 Thousand | -5004.00 | -2.08 Million | -4960.00 | -4915.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 8.4 Million | 2.6 Million | 2.6 Million | - | - |
Other Financing Activities | - | 294.91 Thousand | -2.59 Million | -1.00 | -106.52 Thousand | 2.05 Million |
Accounts receivables | 17.13 Thousand | 63.5 Thousand | -85.5 Thousand | -153.96 Thousand | 53.78 Thousand | -70.64 Thousand |
Accounts payables | -210.35 Thousand | 313.97 Thousand | 345.71 Thousand | 198.89 Thousand | 51.71 Thousand | -244.07 Thousand |
Inventory | -53.84 Thousand | -1415.00 | 6036.00 | 60.73 Thousand | -17.72 Thousand | 24.57 Thousand |
Other working capital | -167.42 Thousand | 188.18 Thousand | 158.35 Thousand | 117.56 Thousand | -48.39 Thousand | 29.19 Thousand |
Cash at beginning of period | 8.34 Million | 492.94 Thousand | 1.26 Million | 1.98 Million | 2.33 Million | 1.27 Million |
Cash at end of period | 6.75 Million | 8.34 Million | 492.94 Thousand | 492.94 Thousand | 1.26 Million | 2.33 Million |
Capital Expenditure | -38.89 Thousand | -6195.00 | -49.13 Thousand | -51.76 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.58 Million | 7.85 Million | -772.38 Thousand | -1.49 Million | -1.06 Million | 1.05 Million |
Free Cash Flow | -1.58 Million | -840.12 Thousand | -767.37 Thousand | -3.57 Million | -1.06 Million | -995.13 Thousand |
HOFBF
ELRXF
ECRFF
016610
BIOCON
0JSP